期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 17, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/ijms17010033
关键词
radio-immunotherapy; radionuclide; targeted therapy; alpha-emitter; beta-emitter; Auger electron; antibody; peptide
资金
- Ministry of Education and Science of The Russian Federation [14.578.21.0030 (RFMEFI57814X0030)]
Targeted radionuclide therapy is one of the most intensively developing directions of nuclear medicine. Unlike conventional external beam therapy, the targeted radionuclide therapy causes less collateral damage to normal tissues and allows targeted drug delivery to a clinically diagnosed neoplastic malformations, as well as metastasized cells and cellular clusters, thus providing systemic therapy of cancer. The methods of targeted radionuclide therapy are based on the use of molecular carriers of radionuclides with high affinity to antigens on the surface of tumor cells. The potential of targeted radionuclide therapy has markedly grown nowadays due to the expanded knowledge base in cancer biology, bioengineering, and radiochemistry. In this review, progress in the radionuclide therapy of hematological malignancies and approaches for treatment of solid tumors is addressed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据